We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Life Technologies Acquires Advanced Microscopy Group

By LabMedica International staff writers
Posted on 12 Nov 2012
Print article
Image: The EVOS XL Core Microscope (Photo courtesy of Advanced Microscopy Group).
Image: The EVOS XL Core Microscope (Photo courtesy of Advanced Microscopy Group).
Life Technologies (Carlsbad, CA, USA) bought Advanced Microscopy Group (AMG; Bothell, WA, USA), which makes microscopes, digital imaging equipment, and software. AMG provides Life Technologies with a complete set of imaging products ranging across of a large range of functionality and prices. In addition, it establishes a foundation for new product innovation in fluorescent and bright field imaging devices. Data on financial terms of the deal are not being disclosed. AMG's existing business will remain in Bothell, Washington, and will join Life Technologies' Flow Cytometry and Imaging business unit.

AMG has a portfolio of imaging instruments that spans basic to advanced microscopy. The EVOS range of instruments improves ease of use by eliminating conventional eyepieces and replacing them with liquid crystal display (LCD) screens. Two entry-level microscopes, EVOS XL and EVOS XL-Core, address the tissue culture market for routine monitoring of cell culture through measurements of cell density and morphology. The instruments are bright field and phase contrast-enabled and come with a range of magnification lens options. The EVOS FL is a multicolor fluorescent microscope with bright field/phase contrast capabilities and a range of objective options.

"Our acquisition of Advanced Microscopy Group brings together two leaders in the cell imaging field," said Peter Dansky, president of Molecular and Cell Biology at Life Technologies. "With AMG's demonstrated excellence in innovative microscopy instrumentation and the Molecular Probes line of market leading imaging reagents, we're now better able to serve our customers with a complete portfolio of integrated solutions for cell analysis optimized for performance and ease of use."

The microscopy market size is estimated to be approximately USD 770 million. AMG's existing business will remain in the state of Washington (USA), and will join Life Technologies ' Flow Cytometry and Imaging business unit.

Related Links:
Life Technologies
Advanced Microscopy Group

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Urine Strips
11 Parameter Urine Strips

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.